Babylon Holdings Ltd
OTC:BBLNF

Watchlist Manager
Babylon Holdings Ltd Logo
Babylon Holdings Ltd
OTC:BBLNF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $2.6k

Babylon Holdings Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Babylon Holdings Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Babylon Holdings Ltd
OTC:BBLNF
Research & Development
-$79.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Research & Development
-$750.1m
CAGR 3-Years
-16%
CAGR 5-Years
-22%
CAGR 10-Years
-29%
Inspire Medical Systems Inc
NYSE:INSP
Research & Development
-$103.2m
CAGR 3-Years
-15%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Research & Development
-$93m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Research & Development
-$88.7m
CAGR 3-Years
4%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
W
Waystar Holding Corp
NASDAQ:WAY
Research & Development
-$54.6m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Babylon Holdings Ltd
Glance View

Market Cap
2.6k USD
Industry
Health Care

Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The company is headquartered in Austin, Texas and currently employs 1,895 full-time employees. The company went IPO on 2021-03-30. The firm's digital clinical platform makes information available to members so that they can monitor their health information on mobile devices, delivering digital care in countries as varied as the United States and Rwanda. The company provides 24/7 digital access to medical professionals in the United States and the United Kingdom. Its platform delivers standardized treatment protocols, administrative practices, technology, and automation, such as care for acute and chronic conditions, including chronic pain, pregnancy, cardiovascular disease, diabetes, and numerous other health concerns in a longitudinal manner. Its flagship holistic solution, Babylon 360, combines its cutting-edge technologies with human clinical expertise and provides managed care for its members across the care continuum.

BBLNF Intrinsic Value
Not Available

See Also

What is Babylon Holdings Ltd's Research & Development?
Research & Development
-79.2m USD

Based on the financial report for Dec 31, 2022, Babylon Holdings Ltd's Research & Development amounts to -79.2m USD.

What is Babylon Holdings Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-16%

Over the last year, the Research & Development growth was -16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett